Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Treasury Shares (2016 - 2025)

Fortress Biotech (FBIO) has 13 years of Treasury Shares data on record, last reported at $5.1 million in Q3 2025.

  • For Q3 2025, Treasury Shares rose 185.2% year-over-year to $5.1 million; the TTM value through Sep 2025 reached $5.1 million, up 185.2%, while the annual FY2024 figure was $4.4 million, 202.65% up from the prior year.
  • Treasury Shares reached $70000.0 in Q1 2020 per FBIO's latest filing.
  • Across five years, Treasury Shares topped out at $23.0 million in Q1 2023 and bottomed at $1.4 million in Q4 2022.
  • Average Treasury Shares over 5 years is $11.1 million, with a median of $5.7 million recorded in 2025.
  • Peak YoY movement for Treasury Shares: skyrocketed 368650.26% in 2021, then plummeted 92.83% in 2023.
  • A 5-year view of Treasury Shares shows it stood at $18.1 million in 2021, then plummeted by 92.41% to $1.4 million in 2022, then soared by 50.86% to $2.1 million in 2023, then skyrocketed by 113.6% to $4.4 million in 2024, then rose by 15.91% to $5.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Treasury Shares were $5.1 million in Q3 2025, $5.7 million in Q2 2025, and $5.5 million in Q1 2025.